These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11700538)

  • 1. An inflammatory drug prospect.
    De Strooper B; König G
    Nature; 2001 Nov; 414(6860):159-60. PubMed ID: 11700538
    [No Abstract]   [Full Text] [Related]  

  • 2. Killing pain, killing neurons?
    Wyss-Coray T
    Nat Med; 2005 May; 11(5):472-3. PubMed ID: 15875048
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
    Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
    Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedicine. Avoiding collateral damage in Alzheimer's disease treatment.
    Glabe C
    Science; 2006 Oct; 314(5799):602-3. PubMed ID: 17068248
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drugs lower Abeta42 and change presenilin 1 conformation.
    Lleó A; Berezovska O; Herl L; Raju S; Deng A; Bacskai BJ; Frosch MP; Irizarry M; Hyman BT
    Nat Med; 2004 Oct; 10(10):1065-6. PubMed ID: 15448688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization.
    Cumming J; Babu S; Huang Y; Carrol C; Chen X; Favreau L; Greenlee W; Guo T; Kennedy M; Kuvelkar R; Le T; Li G; McHugh N; Orth P; Ozgur L; Parker E; Saionz K; Stamford A; Strickland C; Tadesse D; Voigt J; Zhang L; Zhang Q
    Bioorg Med Chem Lett; 2010 May; 20(9):2837-42. PubMed ID: 20347593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of Alzheimer's disease].
    Ishiura S; Hattori C
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(14):2179-85. PubMed ID: 15559301
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific enzyme identified that snips APP into beta-amyloid.
    Senior K
    Drug Discov Today; 2005 Nov; 10(21):1408. PubMed ID: 16243255
    [No Abstract]   [Full Text] [Related]  

  • 9. Amyloid inhibitors and Alzheimer's disease.
    Xia W
    Curr Opin Investig Drugs; 2003 Jan; 4(1):55-9. PubMed ID: 12625030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saving the mind faces high hurdles.
    Travis J
    Science; 2005 Jul; 309(5735):731. PubMed ID: 16051787
    [No Abstract]   [Full Text] [Related]  

  • 11. Knife jugglers. Painkillers shift Alzheimer's protein slicer.
    Davenport RJ
    Sci Aging Knowledge Environ; 2004 Sep; 2004(39):nf89. PubMed ID: 15456907
    [No Abstract]   [Full Text] [Related]  

  • 12. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
    Pollack SJ; Lewis H
    Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42.
    Leuchtenberger S; Kummer MP; Kukar T; Czirr E; Teusch N; Sagi SA; Berdeaux R; Pietrzik CU; Ladd TB; Golde TE; Koo EH; Weggen S
    J Neurochem; 2006 Jan; 96(2):355-65. PubMed ID: 16300630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. sorLA: sorting out APP.
    Shah S; Yu G
    Mol Interv; 2006 Apr; 6(2):74-6, 58. PubMed ID: 16565469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secretases as therapeutic targets for the treatment of Alzheimer's disease].
    Dejaegere T; de Strooper B
    Verh K Acad Geneeskd Belg; 2004; 66(1):29-58; discussion 58-9. PubMed ID: 15074081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
    Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
    J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells.
    Blasko I; Apochal A; Boeck G; Hartmann T; Grubeck-Loebenstein B; Ransmayr G
    Neurobiol Dis; 2001 Dec; 8(6):1094-101. PubMed ID: 11741404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
    Kreft AF; Martone R; Porte A
    J Med Chem; 2009 Oct; 52(20):6169-88. PubMed ID: 19694467
    [No Abstract]   [Full Text] [Related]  

  • 19. gamma-Secretase as a target for drug intervention in Alzheimer's disease.
    Harrison T; Churcher I; Beher D
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):709-19. PubMed ID: 15503873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression".
    Lee HG; Perry G; Zhu X; Nunomura A; Smith MA
    Free Radic Biol Med; 2006 Jul; 41(2):188-9. PubMed ID: 16814097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.